Spring AI 2.0 advances the Java framework for generative AI apps with a Spring Boot 4 baseline, cleaner agentic tooling, Model Context Protocol support and vendor-backed integrations including Azure ...

With one click, developers can implement a Jira issue, whether a story, bug, task, or subtask, and the implementation will generate code from requirements in that issue, Tabnine said. Afterward, ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

This extension for StarUML(http://staruml.io) support to generate Java code from UML model and to reverse Java code to UML model. Install this extension from ...

Anyone can code using AI. But it might come with a hidden cost. Limited time: Save 25% on NBC News subscription Get exclusive reporting, live Q&As and ad-free reading. Over the past year, AI systems ...

The entire source code for Anthropic’s Claude Code command line interface application (not the models themselves) has been leaked and disseminated, apparently due ...

The Java ecosystem has historically been blessed with great IDEs to work with, including NetBeans, Eclipse and IntelliJ from JetBrains. However, in recent years Microsoft's Visual Studio Code editor ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...